Neuro-Oncology Reviews
Volume
26 Number 8
30 April 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 8, 30 April
Cohen
KJ,
et al, PDQ Pediatric Treatment Editorial Board.
Childhood
Ependymoma Treatment (PDQ®): Health Professional Version.
PDQ
Cancer Inf Summ.
2024
Apr 16.
NCBI
Bookshelf ID:
NBK65935.
PMID:
26389373.
Review.
ˍ
Ramírez-Ferrer E, Aguilera-Pena MP, Duffau H.
Functional
and oncological outcomes after right hemisphere glioma resection
in awake versus asleep patients: a systematic review and
meta-analysis.
Neurosurg
Rev. 2024 Apr 16;47(1):160. doi:
10.1007/s10143-024-02370-8. PMID:
38625548.
Review˰
ˍ
Walentynowicz KA, Stead LF, Ellert-Miklaszewska A, Karakoula
K.
Editorial: Glioma: from genetic to
cellular heterogeneity.
Front
Cell Dev Biol. 2024 Apr 16;12:1403595. doi:
10.3389/fcell.2024.1403595. PMID:
38690565. Editorial. ˍ
Wang L, Wang W, Hu D, Liang Y, Liu Z, Zhong T, Wang
X.
Tumor-derived extracellular vesicles
regulate macrophage polarization: role and therapeutic
perspectives.
Front
Immunol. 2024 Apr 16;15:1346587. doi:
10.3389/fimmu.2024.1346587. PMID:
38690261. Review. ˍ
Zhao X, Li R, Guo Y, Wan H, Zhou D.
Laser
interstitial thermal therapy for recurrent glioblastomas: a
systematic review and meta-analysis.
Neurosurg
Rev. 2024 Apr 16;47(1):159. doi:
10.1007/s10143-024-02409-w. PMID:
38625588.
Review;
Meta-analysis˰
ˍ
Durham PG, Butnariu A, Alghorazi R, Pinton G, Krishna V, Dayton
PA.
Current clinical investigations of
focused ultrasound blood-brain barrier disruption: A
review.
Neurotherapeutics.
2024 Apr 17;21(3):e00352. doi:
10.1016/j.neurot.2024.e00352. PMID:
38636309.
Review.
ˍ
Geng Y, Xie L, Li J, Wang Y, Li X.
Bibliometric
analysis of emerging trends and research foci in brainstem tumor
field over 30 years (1992-2023).
Childs
Nerv Syst. 2024 Apr 17. doi:
10.1007/s00381-024-06404-w. PMID:
38630267. Bibliometric analysis˰
ˍ
*Roda D, Veiga P, Melo JB, Carreira IM, Ribeiro IP.
Principles
in the Management of Glioblastoma.
Genes
(Basel). 2024 Apr 17;15(4):501. doi:
10.3390/genes15040501. PMID:
38674436.
Review.
ˍ
Zheng Y, Ong SH, Nga VDW, Vellayappan B.
Adjuvant
radiotherapy versus observation after gross total resection of WHO
grade II ependymoma: a systematic review and
individual-participant data meta-analysis.
Chin
Clin Oncol. 2024 Apr 17:cco-23-136. doi:
10.21037/cco-23-136. PMID:
38644544. Review; Meta-analysis. ˍ
Zoi V, Kyritsis AP, Galani V, Lazari D, Sioka C, Voulgaris S,
Alexiou GA.
The Role of Curcumin in
Cancer: A Focus on the PI3K/Akt Pathway.
Cancers
(Basel). 2024 Apr 18;16(8):1554. doi:
10.3390/cancers16081554. PMID:
38672636.
Review.
ˍ
Amanzadeh Jajin E, Oraee Yazdani S, Zali A, Esmaeili A.
Efficacy
and Safety of Vaccines After Conventional Treatments for Survival
of Gliomas: A Systematic Review and Meta-Analysis.
Oncol
Rev. 2024 Apr 19;18:1374513. doi:
10.3389/or.2024.1374513. PMID:
38707486. Review; Meta-Analysis. ˍ
Bakker A, Ixkes AE, Venugopal H, Ries MG, Lak NSM, de Vos FYFL,
van Vuurden DG, Snijders TJ.
Focused
Ultrasound-Enhanced Liquid Biopsy: A Promising Diagnostic Tool for
Brain Tumor Patients.
Cancers
(Basel). 2024 Apr 19;16(8):1576. doi: 10.3390/cancers16081576.
PMID:
38672658.
Review.
ˍ
*Frosina G.
Advancements in Image-Based
Models for High-Grade Gliomas Might Be Accelerated.
Cancers
(Basel). 2024 Apr 19;16(8):1566. doi:
10.3390/cancers16081566. PMID:
38672647.
Review.
ˍ
Pećina-Šlaus N, Hrašćan R.
Glioma
Stem Cells-Features for New Therapy Design.
Cancers
(Basel). 2024 Apr 19;16(8):1557. doi:
10.3390/cancers16081557. PMID:
38672638.
Review.
ˍ
Kitagawa Y, Kobayashi A, Cahill DP, Wakimoto H, Tanaka
S.
Molecular biology and novel
therapeutics for IDH mutant gliomas: The new era of IDH
inhibitors.
Biochim
Biophys Acta Rev Cancer. 2024 Apr 21;1879(3):189102.
doi:
10.1016/j.bbcan.2024.189102. PMID:
38653436. Review˰
ˍ
Kappel AD, Jha R, Guggilapu S, Smith WJ, Feroze AH, Dmytriw AA,
Vicenty-Padilla J, Alcedo Guardia RE, Gessler FA, Patel NJ, Du R,
See AP, Peruzzi PP, Aziz-Sultan MA, Bernstock JD.
Endovascular
Applications for the Management of High-Grade Gliomas in the
Modern Era.
Cancers
(Basel). 2024 Apr 22;16(8):1594. doi:
10.3390/cancers16081594. PMID:
38672676.
Review.
ˍ
Virani QU, Javed Z, Shamim MS.
RAPNO
efforts in Brain Tumour Outcomes.
J
Pak Med Assoc. 2024 Apr 22;74(5):1005-1006. doi:
10.47391/JPMA.24-39. PMID:
38783459. Review. ˍ
Arvaniti CK, Karagianni MD, Papageorgakopoulou MA, Brotis AG,
Tasiou A, Fountas KN.
The role of
lobectomy in glioblastoma management: A systematic review and
meta-analysis.
Brain
Spine. 2024 Apr 23;4:102823. doi:
10.1016/j.bas.2024.102823. PMID:
39285857. Review. ˍ
McArdle SEB, Nagarajan D, Barish ME.
Editorial:
Improving responses to immunotherapy in glioblastoma
multiforme.
Front
Immunol. 2024 Apr 23;15:1407930. doi:
10.3389/fimmu.2024.1407930. PMID:
38715607. Editorial. ˍ
Montoya
M, Gallus M, Phyu S, Haegelin J, de Groot J, Okada H.
A
Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and
Future Perspectives.
Cells.
2024 Apr 23;13(9):726. doi:
10.3390/cells13090726. PMID:
38727262. Review. ˍ
Oishi T, Koizumi S, Kurozumi K.
Mesenchymal
stem cells as therapeutic vehicles for glioma.
Cancer
Gene Ther. 2024 Apr 23. doi:
10.1038/s41417-024-00775-7. PMID:
38654128. Review˰
ˍ
Wadhwa K, Chauhan P, Kumar S, Pahwa R, Verma R, Goyal R, Singh G,
Sharma A, Rao N, Kaushik D.
Targeting
brain tumors with innovative nanocarriers: bridging the gap
through the blood-brain barrier.
Oncol
Res. 2024 Apr 23;32(5):877-897. doi:
10.32604/or.2024.047278. PMID:
38686045.
Review.
ˍ
Lucke-Wold B, Rangwala BS, Shafique MA, Siddiq MA, Mustafa MS,
Danish F, Nasrullah RMU, Zainab N, Haseeb A.
Focus
on current and emerging treatment options for glioma: A
comprehensive review.
World
J Clin Oncol. 2024 Apr 24;15(4):482-495. doi:
10.5306/wjco.v15.i4.482. PMID:
38689623. Review. ˍ
Tang
Y, Wang M, Yu J, Lv G, Wang Y, Yu B.
The
antitumor action of endocannabinoids in the tumor microenvironment
of glioblastoma.
Front
Pharmacol.
2024 Apr 24;15:1395156. doi:
10.3389/fphar.2024.1395156. PMID:
38720772. Review. ˍ
Al-Lami BS, Al-Lami BS, Al-Lami YS.
Survival
outcomes after using charged particle radiotherapy as a treatment
modality for gliomas: A systematic review and meta-analysis.
J
Med Imaging Radiat Sci. 2024 Apr
25:S1939-8654(24)00106-1. doi:
10.1016/j.jmir.2024.04.003. PMID:
38670903. Review;
Meta-analysis˰ ˍ
Berro A, Assi A, Farhat M, Hatoum L, Saad JP, Mohanna R, Bechara
AMA, Prince G, Hachem MCR, Zalaquett Z, Kourie HR.
Unlocking
Hope: Anti-VEGFR inhibitors and their potential in glioblastoma
treatment.
Crit
Rev Oncol Hematol. 2024 Apr 25:104365. doi:
10.1016/j.critrevonc.2024.104365. PMID:
38677355. Review˰
ˍ
Sanders MI, Gatt D, Lee V, Wharton SB, Bagga V.
Paediatric
cerebellar glioblastoma - long-term survival following surgery and
adjuvant chemoradiotherapy: A case report and literature
review.
Brain
Spine. 2024 Apr 25;4:102819. doi:
10.1016/j.bas.2024.102819. PMID:
38706801. Case report; Review. ˍ
*Vaz-Salgado MÁ, García BC, Pérez IF,
Munárriz BJ, Domarco PS, González AH, Villar MV,
Caro RL, Delgado MLV, Sánchez JMS.
SEOM-GEINO
clinical guidelines for grade 2 gliomas (2023).
Clin
Transl Oncol. 2024 Apr 25. doi:
10.1007/s12094-024-03456-x. PMID:
38662171. Guidelines. ˍ
Xiong S, Qin B, Liu C, Pan Y.
Editorial:
Immunosuppression mechanisms and immunotherapy strategies in
glioblastoma.
Front
Cell Neurosci. 2024 Apr 25;18:1411330. doi:
10.3389/fncel.2024.1411330. PMID:
38725447. Editorial. ˍ
Das AK, Sinha M, Singh SK, Chaudhary A, Boro AK, Agrawal M,
Bhardwaj S, Kishore S, Kumari K.
CAR
T-cell therapy: a potential treatment strategy for pediatric
midline gliomas.
Acta
Neurol Belg. 2024 Apr 26. doi:
10.1007/s13760-024-02519-8. PMID:
38669002. Review˰
ˍ
Ritchey
AK
et
al., PDQ Pediatric Treatment Editorial Board.
Childhood
Ependymoma: Patient
Version.
PDQ
Cancer Inf Sum.
2024 Apr 26.
NCBI
Bookshelf ID:
NBK65742. PMID
26389185.
Review. ˍ
Ritchey
AK,
et al., PDQ Pediatric Treatment Editorial Board.
Diffuse
Intrinsic Pontine Glioma (DIPG): Patient Version.
PDQ
Cancer Inf Sum.
2024 Apr 26.
NCBI
Bookshelf ID:
NBK600525. PMID: 38377270.
Review.
ˍ
Singhto N, Pongphitcha P, Jinawath N, Hongeng S, Chutipongtanate
S.
Extracellular Vesicles for Childhood
Cancer Liquid Biopsy.
Cancers
(Basel). 2024 Apr 26;16(9):1681. doi:
10.3390/cancers16091681. PMID:
38730633. Review. ˍ
Boop S, Shimony N, Boop F.
How modern
treatments have modified the role of surgery in pediatric
low-grade glioma.
Childs
Nerv Syst. 2024 Apr 27. doi:
10.1007/s00381-024-06412-w. PMID:
38676718. Review.
ˍ
Zanotto
A, Glover RN, Zanotto T, Boele FW.
Rehabilitation
in People Living with Glioblastoma: A Narrative Review of the
Literature.
Cancers
(Basel).
2024 Apr 27;16(9):1699. doi:
10.3390/cancers16091699. PMID:
38730651. Review. ˍ
Hoggarth AR, Muthukumar S, Thomas SM, Crowley J, Kiser J, Witcher
MR.
Clinical Theranostics in Recurrent
Gliomas: A Review.
Cancers
(Basel). 2024 Apr 28;16(9):1715. doi:
10.3390/cancers16091715. PMID:
38730666.
Review. ˍ
Eekers DBP, Zegers CML, Ahmed KA, Amelio D, Gupta T, Harrabi SB,
Kazda T, Scartoni D, Seidel C, Shih HA, Minniti G.
Controversies
in neuro-oncology: Focal proton versus photon radiation therapy
for adult brain tumors.
Neurooncol
Pract. 2024 Apr 29;11(4):369-382. doi:
10.1093/nop/npae040. PMID:
39006517. Review. ˍ
Holmberg KO, Borgenvik A, Zhao M, Giraud G, Swartling FJ.
Drivers
Underlying Metastasis and Relapse in Medulloblastoma and Targeting
Strategies.
Cancers
(Basel). 2024 Apr 30;16(9):1752. doi:
10.3390/cancers16091752. PMID:
38730706.
Review. ˍ
***